|
Status |
Public on Apr 26, 2018 |
Title |
HBL-1 treated by EDA replicate 1 |
Sample type |
RNA |
|
|
Source name |
HBL-1 treated by EDA
|
Organism |
Homo sapiens |
Characteristics |
cell line: HBL-1 cell type: B Lymphoma cell line treated with: EDA (1µg/ml) for 6hrs
|
Treatment protocol |
BJAB and HBL-1 cell lines were stimulated for 6 hours with recombinant purified APRIL (1µg/ml) or with EDA (1µg/ml) as control.
|
Growth protocol |
BJAB and HBL-1 cell lines were cultured in RPMI1640 medium and 10% FCS.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNAs were purified from cells with the RNeasy Qiagen purification kit following manufacturer's instructions including an on-column DNase I treatment step to remove any residual contaminant DNA.
|
Label |
biotin
|
Label protocol |
Standard Affymetrix procedures
|
|
|
Hybridization protocol |
Standard Affymetrix procedures
|
Scan protocol |
Standard Affymetrix procedures
|
Description |
BH1 RNA expression data from HBL-1 treated by EDA
|
Data processing |
Data obtained for the whole set of samples were normalized by RMA. affymetrix-algorithm-name = sst-rma-gene-full affymetrix-algorithm-version = 1.0 program-name = Expression Console program-version = 1.4.1.46
|
|
|
Submission date |
Apr 25, 2018 |
Last update date |
Apr 26, 2018 |
Contact name |
Jerome Moreaux |
E-mail(s) |
jerome.moreaux@igh.cnrs.fr
|
Organization name |
CHRU Montpellier
|
Department |
Biological Hematology
|
Lab |
Laboratory for Monitoring Innovative Therapies
|
Street address |
80 Av. Augustin Fliche
|
City |
Montpellier |
ZIP/Postal code |
34295 |
Country |
France |
|
|
Platform ID |
GPL23126 |
Series (1) |
GSE113643 |
Coreceptor delivery of paracrine APRIL to Golgic BCMA lowers immunogenicity of B-cell lymphoma |
|